Literature DB >> 9078299

del(7q) in chronic B-cell lymphoid malignancies.

J M Hernandez1, C Mecucci, L Michaux, A Criel, M Stul, P Meeus, I Wlodarska, A Van Orshoven, J J Cassiman, C De Wolf-Peeters, H Van den Berghe.   

Abstract

Twelve patients with diagnosis of B-cell non-Hodgkin's lymphoma/leukemia and del[7q] were studied for their clinical, cytogenetic, and molecular characteristics. Eleven patients were classified as small cell lymphoma whereas one had a diffuse large cell lymphoma. Lymphoplasmacytic features were observed in six out of eleven small cell lymphomas. Morphologically and immunologically these small cell lymphomas could be classified as chronic lymphocytic leukemia (typical or atypical; 4 cases), marginal zone lymphoma (splenic lymphoma with villous lymphocytes; 1 case), mantle cell lymphoma (2 cases), or nonspecified, non-Hodgkin's lymphoma (4 cases). Eleven of twelve patients presented with peripheral blood and bone marrow involvement. Two of twelve cases showed del[7q] as the sole anomaly. Two different types of deletions were present: ten cases had del(7)(q21q31) and two cases had del(7)(q31q34). Cases that could be molecularly investigated did not show any involvement of BCL2, BCL3, or BCL6, and only one case had BCL1 rearrangement. The data indicate that del(7q) is associated with a subset of mature small B-cell lymphoproliferative disorders of which some but not all show lymphoplasmatic features.

Entities:  

Mesh:

Year:  1997        PMID: 9078299     DOI: 10.1016/s0165-4608(96)00183-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.

Authors:  M Mateo; M Mollejo; R Villuendas; P Algara; M Sanchez-Beato; P Martínez; M A Piris
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Expression of VAV1 in the tumour microenvironment of glioblastoma multiforme.

Authors:  Juan Luis Garcia; Jose Couceiro; Juan Antonio Gomez-Moreta; J M Gonzalez Valero; Angel Santos Briz; Vincent Sauzeau; Eva Lumbreras; Manuel Delgado; Cristina Robledo; Monica Lara Almunia; Xose R Bustelo; Jesus M Hernandez
Journal:  J Neurooncol       Date:  2012-08-04       Impact factor: 4.130

3.  Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.

Authors:  Xiaohui Bi; Meera Hameed; Neena Mirani; Erica Maria Pimenta; Jason Anari; Betsy J Barnes
Journal:  Breast Cancer Res       Date:  2011-11-04       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.